Sunshine Biopharma Replaces Bush & Associates With M&K CPAS as Independent Auditor; No Disagreements Reported

Reuters10-01
Sunshine Biopharma Replaces Bush & Associates With M&<a href="https://laohu8.com/S/TKKD.SI">K</a> CPAS as Independent Auditor; No Disagreements Reported

**Sunshine Biopharma Inc. Changes Independent Auditor** Sunshine Biopharma Inc. announced a change in its independent registered public accounting firm, effective September 24, 2025. The company dismissed Bush & Associates CPA LLC and appointed M&K CPAS, PLLC as its new auditor. The decision was approved unanimously by the board of directors and the audit committee. According to the company's filing, there were no disagreements with Bush & Associates regarding accounting principles, financial disclosures, or audit procedures during the most recent fiscal years or the interim period up to September 24, 2025. Furthermore, Bush & Associates' audit reports for the years ended December 31, 2023 and 2024 contained no adverse opinions or qualifications. Sunshine Biopharma indicated it has not yet received a response letter from Bush & Associates but will file it with the SEC upon receipt.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sunshine Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-25-007338), on September 30, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment